ICD-10 Code C84.77 | Anaplastic large cell lymphoma, ALK-negative, spleen Symptoms, Diagnosis, Billing

Anaplastic large cell lymphoma (ALCL), ALK-negative, is a subtype of non-Hodgkin lymphoma characterized by the proliferation of large, atypical lymphoid cells. This condition primarily affects the spleen and is associated with aggressive clinical behavior. Accurate coding with ICD-10 Code C84.77 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this malignancy.

What is ICD-10 Code C84.77 for Anaplastic large cell lymphoma, ALK-negative, spleen?

ICD-10 Code C84.77 specifically identifies Anaplastic large cell lymphoma, ALK-negative, affecting the spleen. This code is utilized when documenting cases of ALCL that do not express the anaplastic lymphoma kinase (ALK) protein, indicating a distinct clinical pathway. It is crucial for accurate clinical documentation and billing, particularly in oncology settings, to ensure appropriate treatment and resource allocation.

ICD-10 Code C84.77 – Clinical Definition and Explanation of Anaplastic large cell lymphoma, ALK-negative, spleen

Anaplastic large cell lymphoma, ALK-negative, is a hematological malignancy that arises from T-cell precursors and is characterized by the presence of large, atypical lymphocytes. The condition can progress rapidly, leading to significant morbidity and necessitating prompt medical intervention.

Key Clinical Features:

• Presence of large, pleomorphic lymphoid cells in the spleen.
• Common symptoms include lymphadenopathy, fever, and weight loss.
• Aggressive clinical course with potential for systemic involvement.
• Diagnosis typically confirmed through biopsy and immunophenotyping.

ICD-10 Code C84.77 for Anaplastic large cell lymphoma, ALK-negative, spleen – SOAP Notes & Clinical Use

ICD-10 Code C84.77 is integral to SOAP notes, facilitating the documentation of symptoms, assessments, and treatment plans for patients diagnosed with Anaplastic large cell lymphoma, ALK-negative, affecting the spleen. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C84.77 for Anaplastic large cell lymphoma, ALK-negative, spleen Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C84.77 connects subjective patient reports and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-negative, spleen. This code supports continuity of care, facilitates accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C84.77 – Anaplastic large cell lymphoma, ALK-negative, spleen

The management of Anaplastic large cell lymphoma, ALK-negative, requires urgent medical attention, often necessitating hospitalization for intensive treatment.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Chemotherapy regimens such as CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone).
• Consideration of stem cell transplant in eligible patients.
• Management of symptoms such as pain and fever.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.
• Monitoring for febrile neutropenia during chemotherapy.

How to Document Symptoms of Anaplastic large cell lymphoma, ALK-negative, spleen (ICD-10 C84.77) in SOAP Notes

Subjective:

• Patient reports persistent fatigue and unexplained weight loss.
• History of night sweats and intermittent fever.
• Complaints of abdominal discomfort and splenomegaly.

Objective:

• Physical examination reveals splenomegaly and lymphadenopathy.
• Laboratory tests show elevated lactate dehydrogenase (LDH) levels.
• Imaging studies indicate enlarged spleen and lymph nodes.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Anaplastic large cell lymphoma, ALK-negative, spleen (ICD-10 Code C84.77)

Assessment:

• Diagnosis: Anaplastic large cell lymphoma, ALK-negative, spleen, aggressive subtype.
• ICD-10 Code: C84.77.
• Contributing factors include immunosuppression and potential environmental exposures.

Plan:

• Initiate chemotherapy with CHOP regimen.
• Educate patient on potential side effects and the importance of follow-up.
• Schedule regular monitoring of blood counts and imaging studies.

Treatment & Plan Section for ICD-10 Code C84.77 – Anaplastic large cell lymphoma, ALK-negative, spleen

• First-line treatment includes chemotherapy regimens such as CHOP.
• Non-pharmacologic strategies include nutritional support and psychosocial counseling.
• Monitoring through regular imaging and laboratory tests to assess treatment response.
• Follow-up appointments to evaluate for recurrence and manage long-term effects.

Using ICD-10 Code C84.77 for Anaplastic large cell lymphoma, ALK-negative, spleen in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code C84.77 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Anaplastic large cell lymphoma, ALK-negative, spleen

• C84.76 – Anaplastic large cell lymphoma, ALK-positive, spleen
• C83.90 – Diffuse large B-cell lymphoma, unspecified site
• C84.79 – Other specified peripheral T-cell lymphomas

ICD-10 Code C84.77 in Medical Billing and Insurance for Anaplastic large cell lymphoma, ALK-negative, spleen

ICD-10 Code C84.77 is critical for accurate billing in hospital, emergency room, or infectious disease care settings.

Billing Notes:

• Ensure comprehensive documentation of patient history and clinical findings.
• Use the code in conjunction with relevant CPT codes for treatment services.
• Maintain clear records of diagnostic tests and treatment plans to support claims.

Common CPT Pairings: